Jed Johnson

Jed Johnson

Auto-generated profile, based on publicly available information

Jed Johnson

Nanofiber Solutions, Inc. , Hilliard, Ohio

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TFTakuma Fukunishi
Takuma Fukunishi
CBCameron A Best
Cameron A Best
TSTadahisa Sugiura
Tadahisa Sugiura
TSToshihiro Shoji
Toshihiro Shoji
TYTai Yi
Tai Yi
NHNarutoshi Hibino
Narutoshi Hibino
Tissue engineered vascular grafts (TEVGs) have the potential to overcome the issues faced by existing small diameter prosthetic grafts by providing a biodegradable scaffold where the patient’s own cells can engraft and form functional neotissue. However, applying classical approaches to create arterial TEVGs using slow degrading materials with supraphysiological mechanical properties, typically results in limited host cell infiltration, poor remodeling, stenosis, and calcification. The purpose of this study is to evaluate the feasibility of novel small diameter arterial TEVGs created using fast degrading material. A 1.0mm and 5.0mm diameter TEVGs were fabricated with electrospun polycaprolactone (PCL) and chitosan (CS) blend nanofibers. The 1.0mm TEVGs were implanted in mice (n = 3) as an unseeded infrarenal abdominal aorta interposition conduit., The 5.0mm TEVGs were implanted in sheep (n = 6) as an unseeded carotid artery (CA) interposition conduit. Mice were followed with ultrasound and sacrificed at 6 months. All 1.0mm TEVGs remained patent without evidence of thrombosis or aneurysm formation. Based on small animal outcomes, sheep were followed with ultrasound and sacrificed at 6 months for histological and mechanical analysis. There was no aneurysm formation or calcification in the TEVGs. 4 out of 6 grafts (67%) were patent. After 6 months in vivo, 9.1 ± 5.4% remained of the original scaffold. Histological analysis of patent grafts demonstrated deposition of extracellular matrix constituents including elastin and collagen production, as well as endothelialization and organized contractile smooth muscle cells, similar to that of native CA. The mechanical properties of TEVGs were comparable to native CA. There was a significant positive correlation between TEVG wall thickness and CD68+ macrophage infiltration into the scaffold (R2 = 0.95, p = 0.001). The fast degradation of CS in our novel TEVG promoted excellent cellular infiltration and neotissue formation without calcification or aneurysm. Modulating host macrophage infiltration into the scaffold is a key to reducing excessive neotissue formation and stenosis.

1 April 2011 in Acta Biomaterialia
Verified
Journal Article
Closed access
Jin NamJin Nam
Jin Nam
JJJed Johnson
Jed Johnson
JLJohn J. Lannutti
John J. Lannutti
SASudha Agarwal
Sudha Agarwal

1 September 2011 in Neoplasia
Verified
Journal Article
Open access
PAPaula A. Agudelo-Garcia
Paula A. Agudelo-Garcia
JJJessica K. De Jesus
Jessica K. De Jesus
SWShante P. Williams
Shante P. Williams
MNMichal Nowicki
Michal Nowicki
ECEnnio Antonio Chiocca
Ennio Antonio Chiocca
MVMariano S Viapiano
Mariano S Viapiano
A hallmark of malignant gliomas is their ability to disperse through neural tissue, leading to long-term failure of all known therapies. Identifying new antimigratory targets could reduce glioma recurrence and improve therapeutic efficacy, but screens based on conventional migration assays are hampered by the limited ability of these assays to reproduce native cell motility. Here, we have analyzed the motility, gene expression, and sensitivity to migration inhibitors of glioma cells cultured on scaffolds formed by submicron-sized fibers (nanofibers) mimicking the neural topography. Glioma cells cultured on aligned nanofiber scaffolds reproduced the elongated morphology of cells migrating in white matter tissue and were highly sensitive to myosin II inhibition but only moderately affected by stress fiber disruption. In contrast, the same cells displayed a flat morphology and opposite sensitivity to myosin II and actin inhibition when cultured on conventional tissue culture polystyrene. Gene expression analysis indicated a correlation between migration on aligned nanofibers and increased STAT3 signaling, a known driver of glioma progression. Accordingly, cell migration out of glioblastoma-derived neurospheres and tumor explants was reduced by STAT3 inhibitors at subtoxic concentrations. Remarkably, these inhibitors were ineffective when tested at the same concentrations in a conventional two-dimensional migration assay. We conclude that migration of glioma cells is regulated by topographical cues that affect cell adhesion and gene expression. Cell migration analysis using nanofiber scaffolds could be used to reproduce native mechanisms of migration and to identify antimigratory strategies not disclosed by other in vitro models.

1 April 2017 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
TFTakuma Fukunishi
Takuma Fukunishi
CBCameron A. Best
Cameron A. Best
TSTadahisa Sugiura
Tadahisa Sugiura
JOJustin Opfermann
Justin Opfermann
COChin Siang Ong
Chin Siang Ong
NHNarutoshi Hibino
Narutoshi Hibino

1 September 2010 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
YLYong Chae Lim
Yong Chae Lim
JJJed Johnson
Jed Johnson
ZFZhengzheng Fei
Zhengzheng Fei
YWYun Wu
Yun Wu
DFDave F. Farson
Dave F. Farson
LLL. James Lee
L. James Lee

1 December 2009 in Tissue Engineering Part C: Methods
Verified
Journal Article
Closed access
JJJed Johnson
Jed Johnson
MNMichal Nowicki
Michal Nowicki
CLCarol H. Lee
Carol H. Lee
ECE. Antonio Chiocca
E. Antonio Chiocca
MVMariano S Viapiano
Mariano S Viapiano
JLJohn J. Lannutti
John J. Lannutti
Malignant gliomas are the most common tumors originating within the central nervous system and account for over 15,000 deaths annually in the United States. The median survival for glioblastoma, the most common and aggressive of these tumors, is only 14 months. Therapeutic strategies targeting glioma cells migrating away from the tumor core are currently hampered by the difficulty of reproducing migration in the neural parenchyma in vitro. We utilized a tissue engineering approach to develop a physiologically relevant model of glioma cell migration. This revealed that glioma cells display dramatic differences in migration when challenged by random versus aligned electrospun poly-ɛ-caprolactone nanofibers. Cells on aligned fibers migrated at an effective velocity of 4.2 ± 0.39 μm/h compared to 0.8 ± 0.08 μm/h on random fibers, closely matching in vivo models and prior observations of glioma spread in white versus gray matter. Cells on random fibers exhibited extension along multiple fiber axes that prevented net motion; aligned fibers promoted a fusiform morphology better suited to infiltration. Time-lapse microscopy revealed that the motion of individual cells was complex and was influenced by cell cycle and local topography. Glioma stem cell–containing neurospheres seeded on random fibers did not show cell detachment and retained their original shape; on aligned fibers, cells detached and migrated in the fiber direction over a distance sixfold greater than the perpendicular direction. This chemically and physically flexible model allows time-lapse analysis of glioma cell migration while recapitulating in vivo cell morphology, potentially allowing identification of physiological mediators and pharmacological inhibitors of invasion.